Inogen (INGN) Common Equity (2013 - 2026)

Inogen (INGN) has 14 years of Common Equity data on file, last reported at $182.9 million in Q1 2026.

• On a quarterly basis, Common Equity fell 7.6% year-over-year to $182.9 million in Q1 2026; TTM through Mar 2026 was $182.9 million, a 7.6% decrease from a year earlier, with the FY2025 full-year figure at $192.2 million, up 10.57% from the prior year.
• Common Equity for Q1 2026 stood at $182.9 million, down from $192.2 million in the prior quarter.
• Over the last five years, Common Equity for INGN reached as high as $358.3 million in Q1 2022 and fell as low as $173.9 million in Q4 2024.
• Historically, Common Equity has averaged $239.0 million across 5 years, with a median of $199.5 million in 2025.
• Across the five-year window, Common Equity tumbled 34.26% in 2023 and advanced 10.57% in 2025, its largest moves.
• Year by year, Common Equity stood at $297.4 million in 2022, then plunged by 31.13% to $204.8 million in 2023, then retreated by 15.11% to $173.9 million in 2024, then grew by 10.57% to $192.2 million in 2025, then retreated by 4.85% to $182.9 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $182.9 million in Q1 2026, $192.2 million in Q4 2025, and $197.2 million in Q3 2025.